Regulatory PathRegulatory requirements compared

Active substance

Dehydrated alcohol

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
ABLYSINOL99% (5ML)solution · intra-arterialBPI LABSPrescription21 Jun 2018
DEHYDRATED ALCOHOL99% (5ML)solution · intra-arterialACCORD HLTHCAREPrescription23 Jun 2025
DEHYDRATED ALCOHOL99% (5ML)solution · intra-arterialXGEN PHARMSPrescription23 Jun 2025
DEHYDRATED ALCOHOL99% (5ML)solution · intra-arterialBRECKENRIDGEPrescription23 Jun 2025
DEHYDRATED ALCOHOL99% (5ML)solution · intra-arterialINGENUS PHARMS LLCPrescription9 Jul 2025
DEHYDRATED ALCOHOL98% (5ML)solution · intravenousBE PHARMSPrescription23 Oct 2025
ABLYSINOL99% (1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**solution · intra-arterialBPI LABSDiscontinued21 Jun 2018

UK MHRA United Kingdom — marketing authorisations

ProductAuthorisationHolderLegal status
ABSOLUTE ALCOHOL INJECTION BPPL 01883/6119RMACARTHYS LABORATORIES LIMITEDPOM
DEHYDRATED ALCOHOL BP FOR INJECTIONPL 01883/6119RMACARTHYS LABORATORIES LIMITEDPOM

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.